Sunshine Biopharma Inc. Balance Sheet
SBFM|14 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
Sunshine Biopharma Inc. had $30M in total assets and $24M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | $21.8M | $2.0M | $989.9K | $40.5K | $115.2K | $107.5K | $57.5K | $50.8K | $143.4K | $31.2K | $60.7K |
| Accounts Receivable | $3.5M | $3.9M | $2.6M | $1.9M | $7.8K | $1.9K | $430 | $95.0K | - | - | - | - | - | - |
| Inventory | $13.5M | $11.3M | $5.7M | $3.3M | $105.7K | - | - | - | - | - | - | - | - | - |
| Current Assets | $26.9M | $26.0M | $24.9M | $27.3M | $2.2M | $1.0M | $65.7K | $211.5K | $117.2K | $58.5K | $53.9K | $143.4K | $31.2K | $106.4K |
| PP&E (Net) | $557.4K | $546.1K | $365.9K | $394.2K | $7.1K | $19.5K | $32.5K | $269.4K | $60.0K | $5.9K | $4.3K | - | - | - |
| Goodwill | - | - | $0 | - | - | - | - | $665.7K | - | - | - | - | - | - |
| Total Assets | $30.1M | $30.6M | $27.3M | $29.2M | $2.2M | $1.0M | $98.1K | $1.1M | $257.5K | $64.4K | $673.3K | $143.4K | $31.2K | $106.4K |
| Current Liabilities | $6.4M | $6.3M | $5.6M | $6.9M | $91.2K | $1.1M | $833.5K | $912.5K | $751.1K | $274.1K | $1.3M | - | - | - |
| Shareholders' Equity | $23.5M | $21.2M | $21.6M | $211.7K | -$954.8K | -$735.4K | -$55.8K | -$573.4K | -$209.7K | -$597.0K | -$387.6K | -$7.7K | $70.4K | $0 |